SCHEMBL12606307

SCHEMBL12606307

Cn1cc(-c2cc3cccnc3[nH]2)c2cc(CNC(=O)Cc3ccsc3)ccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 1/20 0.53
▸ IGF1R P08069 2/20 0.49
▸ NPY5R Q15761 2/20 0.38
▸ GSK3B P49841 3/20 0.37
▸ JAK2 O60674 2/20 0.37
▸ CDK7 P50613 2/20 0.37
▸ LRRK2 Q5S007 2/20 0.37
▸ AURKB Q96GD4 2/20 0.37
▸ LCK P06239 1/20 0.37
▸ GSK3A P49840 1/20 0.37
▸ BTK Q06187 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ CCNB1 P14635 1/20 0.37
▸ RIPK1 Q13546 5/20 0.36
▸ KDR P35968 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ CCNE1 P24864 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12606292 0.84 SYK (0.61) SYKIGF1RGSK3BJAK2CDK7
SCHEMBL12606282 0.82 SYK (0.58) SYKIGF1RGSK3BJAK2CDK7
SCHEMBL12606271 0.80 SYK (0.66) SYKIGF1RGSK3BJAK2CDK7
SCHEMBL12606259 0.78 IGF1R (0.58) SYKIGF1RGSK3BJAK2CDK7
SCHEMBL12606314 0.78 SYK (0.53) SYKIGF1RGSK3BJAK2CDK7
SCHEMBL1778605 0.77 SYK (0.61) SYKIGF1RGSK3BJAK2CDK7
SCHEMBL7168366 0.77 IGF1R (0.61) SYKIGF1RGSK3BJAK2CDK7
SCHEMBL1777884 0.76 IGF1R (0.63) SYKIGF1RGSK3BJAK2CDK7
SCHEMBL12606280 0.76 SYK (0.51) SYKIGF1RGSK3BJAK2CDK7
SCHEMBL12606327 0.76 SYK (0.53) SYKIGF1RGSK3BJAK2CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943616-B2 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders AVENTIS PHARMACEUTICALS INC. (US) 2011-05-17 — — US disclosed
US-7943616-B2 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders AVENTIS PHARMACEUTICALS INC. (US) 2011-05-17 — — US disclosed
EP-2233486-A1 Azaindoles Aventis Pharma Limited (GB) 2010-09-29 — — EP disclosed
Send feedback